Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.
about
Mineralocorticoid receptor blockade in chronic kidney diseaseHypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional controlIncreased blood pressure in adult offspring of families with Balkan endemic nephropathy: a prospective studyCentral mineralocorticoid receptors and cardiovascular disease.HuR-Dependent Editing of a New Mineralocorticoid Receptor Splice Variant Reveals an Osmoregulatory Loop for Sodium HomeostasisThe physiological impact of the serum and glucocorticoid-inducible kinase SGK1Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive ratsRac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathwayLow renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonatesMineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney diseaseMineralocorticoid Receptor Blocker Protects against Podocyte-Dependent GlomerulosclerosisThe mineralocorticoid receptor: insights into its molecular and (patho)physiological biologyThe kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertensionMineralocorticoid receptor blockade in chronic kidney disease.Role of mineralocorticoid action in the brain in salt-sensitive hypertension.Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.Aldosterone, organ damage and dietary salt.Salt, the renin-angiotensin-aldosterone system and resistant hypertension.RNA-binding protein HuR enhances mineralocorticoid signaling in renal KC3AC1 cells under hypotonicity.Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injuryPF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathyRenoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β₁ in patients with chronic kidney disease.Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.Urinary serum- and glucocorticoid-inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy.SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.
P2860
Q26864370-95833664-19D0-4BF0-A2E5-E98CD1E7F0BEQ28115914-5B6FA188-DCF1-4045-8EED-3671B485439FQ33255004-F528BE7F-E6C0-4AC6-844D-70513118FF37Q33678313-9DDD8A8F-C7CC-46FE-BD74-ED0C8253EF00Q33881594-D12C5A31-432D-4BFC-A758-7F51BF5DAEFAQ33904863-A2AAB506-7CBC-48FF-A0D5-36D60C8377A6Q34065505-A451A98A-74FB-4957-9F78-D134B04224C1Q34388248-E60474EF-EDFF-4E65-92CA-258CB5316DBAQ35142803-08959E0A-FAE1-404C-8212-30F0B0BDA736Q35447336-9CF1F19C-E209-46C9-815A-C0C598268B75Q35626544-FB49D1C5-1A28-42BA-A721-75016007F741Q35868694-23A8D766-EF31-4D39-BA9E-5C57118D7EA5Q36238325-80F6B8D5-423C-4F6C-8BD2-C453F7EF559BQ37826130-21CAE15A-FCEC-4E84-9C43-52466BEDF78DQ37861583-D8245A8D-0AD7-45BA-81BE-F91FEAC47299Q37876462-E70BFC47-3BC7-46F7-9450-470FF5E727EDQ37976974-D94C2C93-F95E-4F52-B9B0-37CF9AF25951Q38117211-6FED3BF5-1CC7-4090-97D0-B71898333E56Q38126410-63A2DE40-5B3D-446A-98FB-8A0A4024F30CQ38661127-753D524D-B4FD-44F3-80D2-67BD5994A97BQ38817871-DD6F49A1-8B19-4657-8954-19FE41B7F859Q40000499-826151C0-D61A-416A-B1A7-8E9CCCB0D9E1Q41901927-B6D9BFAF-965C-4474-B24C-E83FA8C89300Q42672479-319134BB-4F2F-4717-B4E2-ED005E9185C9Q47104109-155374E5-9D37-4FB0-BB3A-E0713EFB8D33Q48321878-BCD4D415-E61D-4BFF-9CE1-337C5C218CE7Q52894668-A61BED78-9BA5-464D-8CCA-87AF78534456Q53276513-CD7FF61D-E894-4B04-90E9-9F74EFF0166AQ54372616-675FD528-DA68-4206-A71C-86642B978479Q54976557-D793FCAF-C4E9-4EEC-83D2-58DFAB898677
P2860
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Increased expression of minera ...... tients with heavy proteinuria.
@en
Increased expression of minera ...... tients with heavy proteinuria.
@en-gb
Increased expression of minera ...... tients with heavy proteinuria.
@nl
type
label
Increased expression of minera ...... tients with heavy proteinuria.
@en
Increased expression of minera ...... tients with heavy proteinuria.
@en-gb
Increased expression of minera ...... tients with heavy proteinuria.
@nl
prefLabel
Increased expression of minera ...... tients with heavy proteinuria.
@en
Increased expression of minera ...... tients with heavy proteinuria.
@en-gb
Increased expression of minera ...... tients with heavy proteinuria.
@nl
P2093
P50
P1433
P1476
Increased expression of minera ...... tients with heavy proteinuria.
@en
P2093
Alexander J Howie
Daniel Zehnder
Kevin S Eardley
Martin Hewison
Susan V Hughes
P304
P356
10.1161/CIRCULATIONAHA.105.539122
P407
P577
2005-09-01T00:00:00Z